FDA Should Allow Linkages Between "Help-Seeking" and Full Product Ads, Pfizer Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Similarities between disease awareness ads and full product ads, which contain risk information, could benefit consumers, Pfizer says in comments on FDA's draft DTC guidance. The company is working with consumer and medical groups to generate such evidence.
You may also be interested in...
Pfizer Seeks Better Definition Of FDA Limits On Ad Similarity, Proximity
Pfizer is asking FDA to clarify how different and how distant help-seeking ads must be from direct-to-consumer full product ads to comply with the agency's disease awareness draft guidance
Pfizer Seeks Better Definition Of FDA Limits On Ad Similarity, Proximity
Pfizer is asking FDA to clarify how different and how distant help-seeking ads must be from direct-to-consumer full product ads to comply with the agency's disease awareness draft guidance
FDA Extends Comment Period For Direct-To-Consumer Advertising Guidances
The agency has reopened the comment period until Aug. 10 to allow additional time for conducting DTC research, Ad Division Director Tom Abrams says. FDA plans to conduct its own research on the content and format of the brief summary.